<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">
Log In

SmartTRAK Life Sciences News and Analysis Blog

3 min read

Aatru Medical: Next-Gen NPWT for Surgical Incisions

By David Shepard on 6/3/25 9:30 AM

Thomas Lash, COO and co-founder of Aatru Medical, talks about the company’s innovative single-use negative pressure device, NP-Sims, a Negative Pressure Surgical Incision Management System.

Thomas Lash, chief operating officer and co-founder of Aatru Medical elaborates on the company’s strategy to mitigate the risk of surgical site infections through NP-SIMS, their single-use negative pressure surgical incision management system. To listen to the interview, please click on the following video (21:21 minutes). A link to download a complete transcript of the interview is provided below. 

 

SmartTRAK: Hi, this is David Shepard, senior analyst with SmartTRAK. Today it's my pleasure to be joined by Tom Lash, COO and co-founder of Aatru. He's going to talk to us today about a product that he co-invented, called NPSims. Tom, tell us a little about your company and about the product.

Tom Lash: We started the business about eight years ago, a small research and commercialization team with the goal of developing an alternative solution for the single-use, disposable negative pressure wound therapy market.  Kind of a mouthful to say that, but in essence, what we were trying to do is looking at the predicate devices that are on the market, we knew that if we were going to try and have a product that could make an impact on that market segment, it would be necessary for us to find an innovative mode of action to create the negative pressure without the current use of electromechanical pump which powers the leading products that are in use today. They have an electromechanical pump. They're battery-operated. They have software. Those products were primarily devised for the open or chronic wound market, and because of our focus on the surgical incision market, we were able to design something that was different. We believe the current products are probably over-engineered for the surgical incision market. So, our approach was to devise ...

Click the button below to download and read the complete transcript of SmartTRAK's interview with  Aatru Medical's Co-Founder and COO Thomas Lash, conducted by  David Shepard, SmartTRAK Lead Analyst, Orthobio & Regen.Get the Transcript

Topics: Regenerative Medicine Orthobiologics NPWT
Continue Reading
2 min read

Negative Pressure: Still Innovating, Growing and Expanding

By Jay Merkel on 12/17/24 9:13 AM

SmartTRAK examines the market dynamics, innovations and growth drivers for Negative Pressure Wound Therapy.

Since KCI (now  Solventum) introduced the wound V.A.C. to the market in 1996, traditional Negative Pressure Wound Therapy (tNPWT) has become the standard of care in hospitals for the treatment of hard-to-heal wounds .  While tNPWT has and will continue to experience low-single-digit revenue growth over the next several years, most of the growth in this space has been in single-use NPWT (sNPWT). According to SmartTRAK's US External Devices Market Overview, the US Market for sNPWT is forecasted to grow at a 5-year CAGR of roughly +13% . 
 

In this article, SmartTRAK provides an overview of the market dynamics impacting both the tNPWT and sNPWT segments of the US External Devices Market, including:

  • Traditional Negative Pressure
    • Solventum and Smith+Nephew (SNN) are two key players in the tNPWT category, with a combined US market share of almost ... (read more)
  • Single-Use Negative Pressure
    • Like the tNPWT market, both Solventum and SNN are key players in the sNPWT segment, together owning the vast majority of the market. sNPWT has been attracting a lot of interest from wound care companies, large and small, due to its sustained double-digit growth globally. SmartTRAK identifies and discusses three market strategies that are currently playing out in sNPWT as companies position themselves to capture share in this fast-growing segment. They are:
      • Large Dressing Companies Expanding into the sNPWT Adjacency
      • Start-Ups Focus on Pump-Free Products.
      • Growing the Market Through Expanded Use, Clinical Evidence ... (read more)

Click the button below to access and read the complete "Negative Pressure: Still Innovating, Growing and Expanding" article by Jay Merkel, SmartTRAK Sr Analyst, which highlights key large studies on the use of sNPWT in 2024, breaking them out into the studies that show benefits and the studies with moderate or no benefits. Get the Article

Topics: Wound Care NPWT
Continue Reading
All posts
  • There are no suggestions because the search field is empty.

Recent Articles

SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services.

Contact Us

info@smarttrak.com

3943 Irvine Blvd. #150
Irvine, CA 92602

Sign up for the blog Newsletter

© BioMedGPS, LLC. All rights reserved.